EXACT Historical Financial Ratios

EXAS Stock

USD 62.08 0.39 0.63%

EXACT Sciences is recently reporting on over 111 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 4.47 or Days Sales Outstanding of 28.25 will help investors to properly organize and evaluate EXACT Sciences financial condition quickly.

Quick Ratio Current Ratio

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in EXACT Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For more information on how to buy EXACT Stock please use our How to Invest in EXACT Sciences guide.

About EXACT Financial Ratios Analysis

EXACT SciencesFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate EXACT Sciences investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on EXACT financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across EXACT Sciences history.

EXACT Sciences Financial Ratios Chart

At this time, EXACT Sciences' Cash Per Share is comparatively stable compared to the past year. POCF Ratio is likely to gain to 89.63 in 2024, whereas Days Sales Outstanding is likely to drop 28.25 in 2024.

Price To Sales Ratio Ptb Ratio Days Sales Outstanding Book Value Per Share Invested Capital

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing EXACT Sciences stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on EXACT Sciences sales, a figure that is much harder to manipulate than other EXACT Sciences multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.

Invested Capital

Invested capital represents the total cash investment that shareholders and debt holders have contributed to EXACT Sciences. There are two different methods for calculating EXACT Sciences invested capital: operating approach and financing approach. Understanding EXACT Sciences invested capital allows investors to calculate measures of performance such as return on invested capital or return on capital employed.

Most ratios from EXACT Sciences' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into EXACT Sciences current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in EXACT Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For more information on how to buy EXACT Stock please use our How to Invest in EXACT Sciences guide.At this time, EXACT Sciences' Cash Per Share is comparatively stable compared to the past year. POCF Ratio is likely to gain to 89.63 in 2024, whereas Days Sales Outstanding is likely to drop 28.25 in 2024.

	2021	2022	2023	2024 (projected)
Days Sales Outstanding	44.75	27.68	29.73	28.25
PTB Ratio	3.94	2.87	4.24	4.47

Days Sales Outstanding Ptb Ratio

EXACT Sciences fundamentals Correlations

	Price To Sales Ratio	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Average Payables	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe	Ev To Operating Cash Flow
Price To Sales Ratio		-0.34	0.54	0.08	-0.8	-0.82	-0.74	-0.16	-0.34	0.99	-0.74	-0.35	-0.47	-0.54	0.54	-0.22	0.97	0.61	0.03	0.07	0.13	-0.16	-0.12	0.27	-0.24	0.04
Ptb Ratio	-0.34		-0.09	-0.37	0.54	0.4	0.45	0.56	1.0	-0.29	0.35	0.17	-0.17	0.37	-0.01	-0.14	-0.4	-0.07	-0.25	0.27	-0.39	-0.13	-0.01	0.01	0.09	-0.24
Days Sales Outstanding	0.54	-0.09		-0.48	-0.41	-0.41	-0.18	0.24	-0.09	0.6	-0.2	-0.61	-0.86	0.05	0.99	-0.38	0.45	-0.03	0.0	0.1	0.22	-0.32	0.37	0.49	-0.5	0.01
Book Value Per Share	0.08	-0.37	-0.48		0.15	0.12	-0.39	-0.61	-0.37	0.02	-0.08	0.75	0.4	-0.56	-0.49	-0.12	0.16	0.45	0.24	0.3	0.07	0.5	-0.33	-0.55	0.7	0.21
Free Cash Flow Yield	-0.8	0.54	-0.41	0.15		0.91	0.59	0.11	0.54	-0.74	0.8	0.63	0.28	0.44	-0.38	-0.01	-0.84	-0.42	0.04	0.37	-0.09	0.33	0.04	-0.46	0.54	0.04
Operating Cash Flow Per Share	-0.82	0.4	-0.41	0.12	0.91		0.48	0.02	0.4	-0.78	0.95	0.53	0.29	0.42	-0.38	0.02	-0.84	-0.37	0.35	0.16	0.22	0.58	0.09	-0.61	0.43	0.35
Average Payables	-0.74	0.45	-0.18	-0.39	0.59	0.48		0.37	0.45	-0.67	0.47	0.01	0.24	0.45	-0.23	0.18	-0.8	-0.57	-0.3	-0.12	-0.36	-0.34	0.16	0.21	-0.11	-0.32
Capex To Depreciation	-0.16	0.56	0.24	-0.61	0.11	0.02	0.37		0.56	-0.13	0.01	-0.08	-0.41	0.53	0.3	-0.23	-0.19	-0.27	-0.48	-0.05	-0.49	-0.47	0.34	0.45	-0.05	-0.45
Pb Ratio	-0.34	1.0	-0.09	-0.37	0.54	0.4	0.45	0.56		-0.29	0.35	0.17	-0.17	0.37	-0.01	-0.14	-0.4	-0.07	-0.25	0.27	-0.39	-0.13	-0.01	0.01	0.09	-0.24
Ev To Sales	0.99	-0.29	0.6	0.02	-0.74	-0.78	-0.67	-0.13	-0.29		-0.69	-0.37	-0.51	-0.48	0.59	-0.24	0.93	0.55	0.02	0.07	0.14	-0.18	-0.11	0.29	-0.26	0.03
Free Cash Flow Per Share	-0.74	0.35	-0.2	-0.08	0.8	0.95	0.47	0.01	0.35	-0.69		0.27	0.15	0.44	-0.18	0.05	-0.78	-0.41	0.46	0.07	0.41	0.56	0.19	-0.54	0.18	0.47
Roic	-0.35	0.17	-0.61	0.75	0.63	0.53	0.01	-0.08	0.17	-0.37	0.27		0.37	-0.06	-0.57	-0.21	-0.3	0.14	0.04	0.4	-0.2	0.47	-0.15	-0.58	0.94	0.03
Inventory Turnover	-0.47	-0.17	-0.86	0.4	0.28	0.29	0.24	-0.41	-0.17	-0.51	0.15	0.37		-0.11	-0.92	0.7	-0.38	-0.05	0.08	-0.04	-0.05	0.25	-0.32	-0.4	0.26	0.06
Net Income Per Share	-0.54	0.37	0.05	-0.56	0.44	0.42	0.45	0.53	0.37	-0.48	0.44	-0.06	-0.11		0.1	0.03	-0.6	-0.85	-0.27	-0.08	-0.09	-0.07	0.27	0.16	0.09	-0.22
Days Of Inventory On Hand	0.54	-0.01	0.99	-0.49	-0.38	-0.38	-0.23	0.3	-0.01	0.59	-0.18	-0.57	-0.92	0.1		-0.46	0.44	-0.03	-0.01	0.11	0.19	-0.29	0.37	0.45	-0.44	0.0
Payables Turnover	-0.22	-0.14	-0.38	-0.12	-0.01	0.02	0.18	-0.23	-0.14	-0.24	0.05	-0.21	0.7	0.03	-0.46		-0.19	-0.14	0.06	0.03	0.07	-0.02	-0.16	0.03	-0.27	0.06
Capex To Revenue	0.97	-0.4	0.45	0.16	-0.84	-0.84	-0.8	-0.19	-0.4	0.93	-0.78	-0.3	-0.38	-0.6	0.44	-0.19		0.67	0.04	0.07	0.11	-0.13	-0.13	0.23	-0.2	0.04
Cash Per Share	0.61	-0.07	-0.03	0.45	-0.42	-0.37	-0.57	-0.27	-0.07	0.55	-0.41	0.14	-0.05	-0.85	-0.03	-0.14	0.67		0.24	0.15	0.0	0.17	-0.27	-0.21	0.0	0.21
Pocfratio	0.03	-0.25	0.0	0.24	0.04	0.35	-0.3	-0.48	-0.25	0.02	0.46	0.04	0.08	-0.27	-0.01	0.06	0.04	0.24		-0.03	0.89	0.82	0.0	-0.59	-0.03	1.0
Interest Coverage	0.07	0.27	0.1	0.3	0.37	0.16	-0.12	-0.05	0.27	0.07	0.07	0.4	-0.04	-0.08	0.11	0.03	0.07	0.15	-0.03		-0.09	0.14	0.03	-0.21	0.41	-0.03
Capex To Operating Cash Flow	0.13	-0.39	0.22	0.07	-0.09	0.22	-0.36	-0.49	-0.39	0.14	0.41	-0.2	-0.05	-0.09	0.19	0.07	0.11	0.0	0.89	-0.09		0.71	0.09	-0.45	-0.14	0.91
Pfcf Ratio	-0.16	-0.13	-0.32	0.5	0.33	0.58	-0.34	-0.47	-0.13	-0.18	0.56	0.47	0.25	-0.07	-0.29	-0.02	-0.13	0.17	0.82	0.14	0.71		-0.12	-0.87	0.45	0.83
Days Payables Outstanding	-0.12	-0.01	0.37	-0.33	0.04	0.09	0.16	0.34	-0.01	-0.11	0.19	-0.15	-0.32	0.27	0.37	-0.16	-0.13	-0.27	0.0	0.03	0.09	-0.12		0.21	-0.1	0.01
Income Quality	0.27	0.01	0.49	-0.55	-0.46	-0.61	0.21	0.45	0.01	0.29	-0.54	-0.58	-0.4	0.16	0.45	0.03	0.23	-0.21	-0.59	-0.21	-0.45	-0.87	0.21		-0.5	-0.58
Roe	-0.24	0.09	-0.5	0.7	0.54	0.43	-0.11	-0.05	0.09	-0.26	0.18	0.94	0.26	0.09	-0.44	-0.27	-0.2	0.0	-0.03	0.41	-0.14	0.45	-0.1	-0.5		-0.02
Ev To Operating Cash Flow	0.04	-0.24	0.01	0.21	0.04	0.35	-0.32	-0.45	-0.24	0.03	0.47	0.03	0.06	-0.22	0.0	0.06	0.04	0.21	1.0	-0.03	0.91	0.83	0.01	-0.58	-0.02

Click cells to compare fundamentals

EXACT Sciences Account Relationship Matchups

EXACT Sciences fundamentals Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Price To Sales Ratio	13.85	13.43	7.55	4.19	5.33	5.06
Ptb Ratio	5.31	7.09	3.94	2.87	4.24	4.47
Days Sales Outstanding	54.3	57.07	44.75	27.68	29.73	28.25
Book Value Per Share	17.43	18.68	19.77	17.26	17.46	18.33
Free Cash Flow Yield	(0.0236)	0.003602	(0.0178)	(0.0502)	0.002396	0.002516
Operating Cash Flow Per Share	(0.57)	(0.88)	0.9	(0.6)	0.87	0.91
Stock Based Compensation To Revenue	0.12	0.1	0.19	0.0992	0.0925	0.0879
Capex To Depreciation	3.42	0.39	0.75	1.09	0.6	0.63
Pb Ratio	5.31	7.09	3.94	2.87	4.24	4.47
Ev To Sales	14.73	13.41	8.71	5.25	6.11	5.81
Free Cash Flow Per Share	(2.19)	0.48	(1.39)	(2.48)	0.18	0.19
Roic	(0.23)	(0.12)	(0.0234)	(0.11)	(0.0395)	(0.0415)
Inventory Turnover	3.51	3.84	4.37	4.86	5.13	3.13
Net Income Per Share	(0.64)	(5.61)	(3.48)	(3.54)	(1.13)	(1.19)
Days Of Inventory On Hand	103.96	95.05	83.54	75.15	71.12	127.99
Payables Turnover	8.34	9.92	6.76	7.67	8.3	5.14
Sales General And Administrative To Revenue	0.4	0.32	0.45	0.35	0.57	0.54
Capex To Revenue	0.2	0.0431	0.0768	0.1	0.0497	0.0472
Cash Per Share	2.47	12.17	6.01	3.58	4.32	4.61
Pocfratio	(105.54)	146.72	(130.44)	(39.06)	85.36	89.63
Interest Coverage	(3.8)	(5.82)	(44.9)	(29.42)	(8.8)	(9.24)
Capex To Operating Cash Flow	(1.49)	0.47	(1.33)	(0.96)	0.8	0.84
Pfcf Ratio	(42.32)	277.61	(56.03)	(19.93)	417.4	438.27
Days Payables Outstanding	43.74	36.78	53.97	47.61	43.97	41.77
Income Quality	1.37	(0.16)	0.17	0.36	(0.76)	(0.73)
Roe	(0.0367)	(0.3)	(0.18)	(0.2)	(0.0649)	(0.0682)
Ev To Operating Cash Flow	(112.23)	146.52	(150.47)	(48.92)	97.85	102.74
Pe Ratio	(144.52)	(23.6)	(22.39)	(14.0)	(65.28)	(62.02)
Return On Tangible Assets	(0.2)	(0.12)	(0.0725)	(0.26)	(0.0922)	(0.0968)
Ev To Free Cash Flow	(45.0)	277.24	(64.63)	(24.97)	478.45	502.37
Earnings Yield	(0.006919)	(0.0424)	(0.0447)	(0.0714)	(0.0153)	(0.0161)
Intangibles To Total Assets	0.037	0.0304	0.67	0.42	0.66	0.69
Net Debt To E B I T D A	(3.53)	0.0428	(3.31)	(5.7)	46.55	48.88
Current Ratio	2.36	3.82	2.76	2.38	2.32	2.2
Tangible Book Value Per Share	(0.45)	4.88	(6.08)	(7.14)	(6.17)	(5.87)
Receivables Turnover	6.72	6.4	8.16	13.19	12.28	7.02
Graham Number	15.84	48.58	39.32	37.05	21.1	12.46
Shareholders Equity Per Share	17.43	18.68	19.77	17.26	17.46	18.33

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for EXACT Stock Analysis

When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

EXACT Historical Financial Ratios

About EXACT Financial Ratios Analysis

EXACT Sciences Financial Ratios Chart

Price To Sales Ratio

Ptb Ratio

Book Value Per Share

Invested Capital

EXACT Sciences fundamentals Correlations

EXACT Sciences Account Relationship Matchups

High Positive Relationship

High Negative Relationship

EXACT Sciences fundamentals Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for EXACT Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Pb Ratio	+ 1.0	Ptb Ratio
Ev To Operating Cash Flow	+ 1.0	Pocfratio
Ev To Sales	+ 0.99	Price To Sales Ratio
Days Of Inventory On Hand	+ 0.99	Days Sales Outstanding
Capex To Revenue	+ 0.97	Price To Sales Ratio
Free Cash Flow Per Share	+ 0.95	Operating Cash Flow Per Share

Days Of Inventory On Hand	- 0.92	Inventory Turnover
Income Quality	- 0.87	Pfcf Ratio
Inventory Turnover	- 0.86	Days Sales Outstanding
Cash Per Share	- 0.85	Net Income Per Share
Capex To Revenue	- 0.84	Operating Cash Flow Per Share
Capex To Revenue	- 0.84	Free Cash Flow Yield